Stem Cell Discovery
Vol.4 No.4(2014), Article ID:49721,7 pages DOI:10.4236/scd.2014.44009

A Review on the Biology of Cancer Stem Cells

Mansouri Atena1, Abbaszadegan Mohammad Reza1,2, Gholamin Mehran2*

1Human Genetic Division, Immunology Research Center, Avicenna Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran

2Medical Generics Research Center, Medical School, Mashhad University of Medical Sciences, Mashhad, Iran

Email: *GholaminM@mums.ac.ir

Copyright © 2014 by authors and Scientific Research Publishing Inc.

This work is licensed under the Creative Commons Attribution International License (CC BY).

http://creativecommons.org/licenses/by/4.0/

Received 23 July 2014; revised 18 August 2014; accepted 11 September 2014

ABSTRACT

Cancer Stem Cells (CSC) have the ability to self-renew and are present in most tissues including breast, brain, lung, prostates, testis, ovary, esophagus, colon, and liver. Their origin is yet to be discovered, though a series of hypotheses have been proposed in this regard. CSCs play a role in not only the creation of cancer, but also in its evolution, metastasis, and recurrence. CSCs have an important role in cancer therapy and the resistance towards chemotherapeutic agents. This article reviews the characteristics of cancer stem cells in terms of origin, resistance towards chemotherapy, methods of isolation, and cancer therapy.

Keywords:Cancer, Stem Cells, CSC

2. Conclusion

In spite of all the analyses and studies on CSCs, all strategies of its treatment are under-test theories. The works published so far have not found a way to overcome resistance to chemotherapy, while it seems that CSC is a significant factor. If we come to this conclusion that CSCs are a key molecule in response to resistance towards chemotherapy, the immediate need for an increase in clinical and laboratory studies is supporting biologic treatments. Absolute understanding of tumor biology and investigations into the true role of cancer stem cells to tumor heterogeneity have so far largely been disadvantaged by the lack of dependable and advanced experimental Systems. There is hope that related studies can tell us further on the functional properties of cancer stem cells.

References

  1. Bjerkvig, R., Tysnes, B.B., Aboody, K.S., Najbauer, J. and Terzis, A.J. (2005) Opinion: The Origin of the Cancer Stem Cell: Current Controversies and New Insights. Nature Reviews Cancer, 5, 899-904.
  2. Soltanian, S. and Matin, M.M. (2012) Cancer Stem Cells and Cancer Therapy. Tumor Biology, 32, 425-440.
  3. Huntly, B.J. and Gilliland, D.G. (2005) Leukaemia Stem Cells and the Evolution of Cancer-Stem-Cell Research. Nature Reviews Cancer, 5, 311-321. http://dx.doi.org/10.1038/nrc1592
  4. Bonnet, D. and Dick, J.E. (1997) Human Acute Myeloid Leukemia Is Organized as a Hierarchy That Originates from a Primitive Hematopoietic Cell. Nature Medicine, 7, 730-737.
  5. Lapidot, T., et al. (1994) A Cell Initiating Human Acute Myeloid Leukaemia after Transplantation into SCID Mice. Nature, 367, 645-648.
  6. Cammareri, P., Lombardo, Y., Francipane, M.G., Bonventre, S., Todaro, M. and Stassi, G. (2008) Isolation and Culture of Colon Cancer Stem Cells. Methods in Cell Biology, 311-324.
  7. O’Brien, C.A., Pollett, A., Gallinger, S. and Dick, J.E. (2007) A Human Colon Cancer Cell Capable of Initiating Tumour Growth in Immunodeficient Mice. Nature, 445, 106-110.
  8. Ischenko, I., Seeliger, H., Jauch, K.W. and Bruns, C.J. (2009) Metastatic Activity and Chemotherapy Resistance in Human Pancreatic Cancer—Influence of Cancer Stem Cells. Surgery, 146, 430-434.
  9. Ouhtit, A., Abd Elmageed, Z.Y., Abdraboh, M.E., Lioe, T.F. and Raj, M.H.G. (2007) In Vivo Evidence for the Role of CD44s in Promoting Breast Cancer Metastasis to the Liver. The American Journal of Pathology, 171, 2033-2039.
  10. Maenhaut, C., Dumont, J.E., Roger, P.P. and van Staveren, W.C. (2010) Cancer Stem Cells: A Reality, a Myth, a Fuzzy Concept or a Misnomer? Carcinogenesis, 31, 149-158. http://dx.doi.org/10.1093/carcin/bgp259
  11. Patrawala, L., Calhoun, T., Schneider-Broussard, R., Li, H., Bhatia, B., Tang, S., Reilly, J.G., Chandra, D., Zhou, J., Claypool, K., Coghlan, L. and Tang, D.G. (2006) Highly Purified CD44+ Prostate Cancer Cells from Xenograft Human Tumors Are Enriched in Tumorigenic and Metastatic Progenitor Cells. Oncogene, 25, 1696-1708. http://dx.doi.org/10.1038/sj.onc.1209327
  12. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J. and Clarke, M.F. (2003) Prospective Identification of Tumorigenic Breast Cancer Cells. Proceedings of the National Academy of Sciences of the United States of America, 100, 3983-3988. http://dx.doi.org/10.1073/pnas.0530291100
  13. Klonisch, T., Wiechec, E., Hombach-Klonisch, S., Ande, S.R., Wesselborg, S., Schulze-Osthoff, K. and Los, M. (2008) Cancer Stem Cell Markers in Common Cancers-Therapeutic Implications. Trends in Molecular Medicine, 14, 450-460. http://dx.doi.org/10.1016/j.molmed.2008.08.003
  14. Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman, R.M., Cusimano, M.D. and Dirks, P.B. (2004) Identification of Human Brain Tumour Initiating Cells. Nature, 432, 396-401. http://dx.doi.org/10.1038/nature03128
  15. Annabi, B., Rojas-Sutterlin, S., Laflamme, C., Lachambre, M.P., Rolland, Y., Sartelet, H. and Beliveau, R. (2008) Tumor Environment Dictates Medulloblastoma Cancer Stem Cell Expression and Invasive Phenotype. Molecular Cancer Research, 6, 907-916. http://dx.doi.org/10.1158/1541-7786.MCR-07-2184
  16. Shien, K., Toyooka, S., Ichimura, K., Soh, J., Furukawa, M., Maki, Y., Muraoka, T., Tanaka, N., Ueno, T., Asano, H., Tsukuda, K., Yamane, M., Oto, T., Kiura, K. and Miyoshi, S. (2012) Prognostic Impact of Cancer Stem Cell-Related Markers in Non-Small Cell Lung Cancer Patients Treated with Induction Chemoradiotherapy. Lung Cancer, 77, 162-167. http://dx.doi.org/10.1016/j.lungcan.2012.02.006
  17. Kure, S., Matsuda, Y., Hagio, M., Ueda, J., Naito, Z. and Ishiwata, T. (2012) Expression of Cancer Stem Cell Markers in Pancreatic Intraepithelial Neoplasias and Pancreatic Ductal Adenocarcinomas. International Journal of Oncology, 41, 1314-1324.
  18. Ricci-Vitiani, L., Lombardi, D.G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C. and De Maria, R. (2007) Identification and Expansion of Human Colon-Cancer-Initiating Cells. Nature, 445, 111-115. http://dx.doi.org/10.1038/nature05384
  19. Fang, D., Nguyen, T.K., Leishear, K., Finko, R., Kulp, A.N., Hotz, S., Van Belle, P.A., Xu, X., Elder, D.E. and Herlyn, M. (2005) A Tumorigenic Subpopulation with Stem Cell Properties in Melanomas. Cancer Research, 65, 9328-9337. http://dx.doi.org/10.1158/0008-5472.CAN-05-1343
  20. Boman, B.M. and Wicha, M.S. (2008) Cancer Stem Cells: A Step toward the Cure. Journal of Clinical Oncology, 26, 2795-2799. http://dx.doi.org/10.1200/JCO.2008.17.7436
  21. Bertolini, G., Roz, L., Perego, P., Tortoreto, M., Fontanella, E., Gatti, L., Pratesi, G., Fabbri, A., Andriani, F., Tinelli, S., Roz, E., Caserini, R., Lo Vullo, S., Camerini, T., Mariani, L., Delia, D., Calabro, E., Pastorino, U. and Sozzi, G. (2009) Highly Tumorigenic Lung Cancer CD133+ Cells Display Stem-Like Features and Are Spared by Cisplatin Treatment. Proceedings of the National Academy of Sciences of the United States of America, 106, 16281-16286. http://dx.doi.org/10.1073/pnas.0905653106
  22. Cantley, L.C., Dalton, W.S., DuBois, R.N., Finn, O.J., Futreal, P.A., Golub, T.R., et al. (2012) AACR Cancer Progress Report 2012. Clinical Cancer Research, 18, S1-S100. http://dx.doi.org/10.1158/1078-0432.CCR-12-2891
  23. Hermann, P.C., Huber, S.L., Herrler, T., Aicher, A., Ellwart, J.W., Guba, M., Bruns, C.J. and Heeschen, C. (2007) Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer. Cell Stem Cell, 1, 313-323. http://dx.doi.org/10.1016/j.stem.2007.06.002
  24. Wang, Q., Chen, Z.G., Du, C.Z., Wang, H.W., Yan, L. and Gu, J. (2009) Cancer Stem Cell Marker CD133+ Tumour Cells and Clinical Outcome in Rectal Cancer. Histopathology, 55, 284-293. http://dx.doi.org/10.1111/j.1365-2559.2009.03378.x
  25. Stassi, G., Todaro, M., Zerilli, M., Ricci-Vitiani, L., Di Liberto, D., Patti, M., Florena, A., Di Gaudio, F., Di Gesù, G. and De Maria, R. (2003) Thyroid Cancer Resistance to Chemotherapeutic Drugs via Autocrine Production of Interleukin-4 and Interleukin-10. Cancer Research, 63, 6784-6790.
  26. Dancescu, M., RubioTrujillo, M., Biron, G., Bron, D., Delespesse, G. and Sarfati, M. (1992) Interleukin 4 Protects Chronic Lymphocytic Leukemic B Cells from Death by Apoptosis and Upregulates Bcl-2 Expression. Journal of Experimental Medicine, 176, 1319-1326. http://dx.doi.org/10.1084/jem.176.5.1319
  27. Rich, J.N. and Bao, S.D. (2007) Chemotherapy and Cancer Stem Cells. Cell Stem Cell, 1, 353-355. http://dx.doi.org/10.1016/j.stem.2007.09.011
  28. Chuthapisith, S. (2011) Cancer Stem Cells and Chemoresistance. InTech, Shanghai.
  29. Signore, M., Ricci-Vitiani, L. and De Maria, R. (2013) Targeting Apoptosis Pathways in Cancer Stem Cells. Cancer Letters, 332, 374-382. http://dx.doi.org/10.1016/j.canlet.2011.01.013
  30. Avenda?o, C. and Menéndez, J.C. (2002) Inhibitors of Multidrug Resistance to Antitumor Agents (MDR). Current Medicinal Chemistry, 9, 159-193. http://dx.doi.org/10.2174/0929867023371175
  31. Takaishi, S., Okumura, T., Tu, S.P., Wang, S.S.W., Shibata, W., Vigneshwaran, R., et al. (2009) Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44. Stem Cells, 27, 1006-1020. http://dx.doi.org/10.1002/stem.30
  32. Chiou, S.H., Hung, S.C., Kao, C.L., Chen, Y.W., Wong, T.T., Chien, C.S., Lo, J.F., et al. (2008) Identification of CD133-Positive Radioresistant Cells in Atypical Teratoid/Rhabdoid Tumor. PLoS ONE, 3, e2090. http://dx.doi.org/10.1371/journal.pone.0002090
  33. Bao, S., Wu, Q., Sathornsumetee, S., Hao, Y., Li, Z., Hjelmeland, A.B., Shi, Q., McLendon, R.E., Bigner, D.D. and Rich, J.N. (2006) Stem Cell-Like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor. Cancer Research, 66, 7843-7848. http://dx.doi.org/10.1158/0008-5472.CAN-06-1010
  34. van Staveren, W.C., Solís, D.Y., Hébrant, A., Detours, V., Dumont, J.E. and Maenhaut, C. (2009) Human Cancer Cell Lines: Experimental Models for Cancer Cells in Situ? For Cancer Stem Cells? Biochimica et Biophysica Acta, 1795, 92-103.
  35. Lee, J., Kotliarova, S., Kotliarov, Y., Li, A.G., Su, Q., Donin, N.M., et al. (2006) Tumor Stem Cells Derived from Glioblastomas Cultured in bFGF and EGF More Closely Mirror the Phenotype and Genotype of Primary Tumors than Do Serum-Cultured Cell Lines. Cancer Cell, 9, 391-403. http://dx.doi.org/10.1016/j.ccr.2006.03.030
  36. Koch, U., Krause, M. and Baumann, M. (2010) Cancer Stem Cells at the Crossroads of Current Cancer Therapy Failures-Radiation Oncology Perspective. Seminars in Cancer Biology, 20, 116-124. http://dx.doi.org/10.1016/j.semcancer.2010.02.003

NOTES

*Corresponding author.

Journal Menu >>